Why is Neuland Labs. falling/rising?

As of 26-Sep, Neuland Laboratories Ltd is experiencing a decline in its stock price, currently at Rs 13,961.00, which reflects a decrease of Rs 854.8 or 5.77%. The stock has underperformed its sector by 3.43% today and has been on a downward trend for the last two days, resulting in a total decline of 7.07%. Additionally, the stock touched an intraday low of Rs 13,856.85. Over the past week, it has fallen by 9.50%, while it has shown a modest gain of 6.31% over the last month. Despite strong historical performance with a 931.86% increase over three years, recent financial results have been disappointing, with a significant drop in net sales and profits, leading to negative sentiment among investors.
In the broader market context, the Sensex has decreased by 2.66% over the past week, indicating that the stock's short-term underperformance is more pronounced than the overall market trend. The pharmaceuticals and drugs sector has also faced a decline of 2.35%, contributing to the negative sentiment surrounding Neuland Laboratories. The company's ability to service debt remains strong, with a low Debt to EBITDA ratio, and it has high institutional holdings, which typically provide stability. However, the company has reported negative results for four consecutive quarters, with a notable fall in net sales and profits, leading to concerns about its long-term growth potential and resulting in a premium valuation compared to its peers.